{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:01:57Z","timestamp":1789693317306,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2125"],"award-info":[{"award-number":["JPMJSP2125"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07000"],"award-info":[{"award-number":["22K07000"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02848"],"award-info":[{"award-number":["22H02848"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019868","name":"Chukyo Longevity Medical and Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24gm1210009"],"award-info":[{"award-number":["JP24gm1210009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Toyoaki Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58893-1","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:34:28Z","timestamp":1782308068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injury"],"prefix":"10.1038","volume":"16","author":[{"given":"Daishi","family":"Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Mii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutoshi","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ushida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji M.","family":"Nishiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-6116","authenticated-orcid":false,"given":"Atsushi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"58893_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","volume":"51","author":"JC Pastor","year":"2016","unstructured":"Pastor, J. C. et al. Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res. 51, 125\u2013155 (2016).","journal-title":"Prog Retin Eye Res."},{"key":"58893_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376, 124\u2013136 (2010).","journal-title":"Lancet"},{"key":"58893_CR3","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G. & Wong, T. Y. Age-related macular degeneration. Lancet 379, 1728\u20131738 (2012).","journal-title":"Lancet"},{"key":"58893_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1172\/JCI31030","volume":"117","author":"M Friedlander","year":"2007","unstructured":"Friedlander, M. Fibrosis and diseases of the eye. J. Clin. Invest. 117, 576\u2013586 (2007).","journal-title":"J. Clin. Invest."},{"key":"58893_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","volume":"453","author":"GC Gurtner","year":"2008","unstructured":"Gurtner, G. C., Werner, S., Barrandon, Y. & Longaker, M. T. Wound repair and regeneration. Nature 453, 314\u2013321 (2008).","journal-title":"Nature"},{"key":"58893_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653\u2013660 (2003).","journal-title":"Nat. Med."},{"key":"58893_CR7","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob Health"},{"key":"58893_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","volume":"40","author":"KYC Teo","year":"2020","unstructured":"Teo, K. Y. C. et al. Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration. Retina 40, 2285\u20132295 (2020).","journal-title":"Retina"},{"key":"58893_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajo.2020.02.016","volume":"214","author":"EH Souied","year":"2020","unstructured":"Souied, E. H. et al. Spectral-domain optical coherence tomography analysis of fibrotic lesions in neovascular age-related macular degeneration. Am. J. Ophthalmol. 214, 151\u2013171 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"58893_CR10","doi-asserted-by":"crossref","unstructured":"Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G. & Hawkins, B. S. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst. Rev. 2019, CD005139 (2019).","DOI":"10.1002\/14651858.CD005139.pub4"},{"key":"58893_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.5.2.9","volume":"5","author":"JW Miller","year":"2016","unstructured":"Miller, J. W. VEGF: From discovery to therapy: The Champalimaud award lecture. Trans. Vis. Sci. Tech. 5, 9 (2016).","journal-title":"Trans. Vis. Sci. Tech."},{"key":"58893_CR12","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R. & Zhang, K. Seven-year outcomes in ranibizumab-treated patients in Anchor, Marina, and HORIZON. Ophthalmology 120, 2292\u20132299 (2013).","journal-title":"Ophthalmology"},{"key":"58893_CR13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire, M. G. et al. Five-year outcomes with anti\u2013vascular endothelial growth factor treatment of neovascular age-related macular degeneration. Ophthalmology 123, 1751\u20131761 (2016).","journal-title":"Ophthalmology"},{"key":"58893_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.65.10.24","volume":"65","author":"X Zhuang","year":"2024","unstructured":"Zhuang, X. et al. Molecular responses of anti-VEGF therapy in neovascular age-related macular degeneration: Integrative insights from multi-omics and clinical imaging. Invest. Ophthalmol. Vis. Sci. 65, 24 (2024).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58893_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati, J. & Fowler, B. J. Mechanisms of age-related macular degeneration. Neuron 75, 26\u201339 (2012).","journal-title":"Neuron"},{"key":"58893_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ebiom.2018.11.029","volume":"38","author":"K Little","year":"2018","unstructured":"Little, K., Ma, J. H., Yang, N., Chen, M. & Xu, H. Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration\u2014The potential sources and molecular cues for their recruitment and activation. EBiomedicine 38, 283\u2013291 (2018).","journal-title":"EBiomedicine"},{"key":"58893_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-023-02731-y","volume":"20","author":"C Yi","year":"2023","unstructured":"Yi, C. et al. Old age promotes retinal fibrosis in choroidal neovascularization through circulating fibrocytes and profibrotic macrophages. J. Neuroinflammation. 20, 45 (2023).","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"58893_CR18","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1167\/iovs.09-4725","volume":"51","author":"S Tamiya","year":"2010","unstructured":"Tamiya, S., Liu, L. & Kaplan, H. J. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest. Ophthalmol. Vis. Sci. 51, 2755 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58893_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep22288","volume":"6","author":"K Maeda","year":"2016","unstructured":"Maeda, K. et al. Identification of meflin as a potential marker for mesenchymal stromal cells. Sci. Rep. 6, 22288 (2016).","journal-title":"Sci. Rep."},{"key":"58893_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCRESAHA.119.314806","volume":"125","author":"A Hara","year":"2019","unstructured":"Hara, A. et al. Roles of the mesenchymal stromal\/stem cell marker meflin in cardiac tissue repair and the development of diastolic dysfunction. Circ. Res. 125, 414\u2013430 (2019).","journal-title":"Circ. Res."},{"issue":"6","key":"58893_CR21","doi-asserted-by":"publisher","first-page":"2003397","DOI":"10.1183\/13993003.03397-2020","volume":"58","author":"Y Nakahara","year":"2021","unstructured":"Nakahara, Y. et al. Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis. Eur. Respir. J. 58,\u00a02003397 (2021).","journal-title":"Eur. Respir. J."},{"key":"58893_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09331-5","volume":"12","author":"S Minatoguchi","year":"2022","unstructured":"Minatoguchi, S. et al. A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts. Sci. Rep. 12, 5389 (2022).","journal-title":"Sci. Rep."},{"key":"58893_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/gtc.12855","volume":"26","author":"A Hara","year":"2021","unstructured":"Hara, A. et al. Meflin defines mesenchymal stem cells and\/or their early progenitors with multilineage differentiation capacity. Genes Cells 26, 495\u2013512 (2021).","journal-title":"Genes Cells"},{"key":"58893_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/pin.13503","volume":"75","author":"Y Urano","year":"2025","unstructured":"Urano, Y. et al. Superoxide dismutase 2 deficiency in mesenchymal stromal cells induces sympathetic denervation and functional impairment of brown adipose tissue. Pathol. Int. 75, 69\u201381 (2025).","journal-title":"Pathol. Int."},{"key":"58893_CR25","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","volume":"79","author":"Y Mizutani","year":"2019","unstructured":"Mizutani, Y. et al. Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis. Cancer Res. 79, 5367\u20135381 (2019).","journal-title":"Cancer Res."},{"key":"58893_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/cas.14346","volume":"111","author":"Y Miyai","year":"2020","unstructured":"Miyai, Y., Esaki, N., Takahashi, M. & Enomoto, A. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives. Cancer Sci. 111, 1047\u20131057 (2020).","journal-title":"Cancer Sci."},{"key":"58893_CR27","doi-asserted-by":"publisher","first-page":"e202101230","DOI":"10.26508\/lsa.202101230","volume":"5","author":"Y Miyai","year":"2022","unstructured":"Miyai, Y. et al. Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade. Life Sci. Alliance. 5, e202101230 (2022).","journal-title":"Life Sci. Alliance"},{"key":"58893_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.gastro.2020.11.011","volume":"160","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi, H. et al. The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology 160, 1224\u20131239.e30 (2021).","journal-title":"Gastroenterology"},{"key":"58893_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/path.6211","volume":"262","author":"R Ando","year":"2024","unstructured":"Ando, R. et al. Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas. J. Pathol. 262, 61\u201375 (2024).","journal-title":"J. Pathol."},{"key":"58893_CR30","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/cancers14143315","volume":"14","author":"R Ando","year":"2022","unstructured":"Ando, R. et al. Good and bad stroma in pancreatic cancer: Relevance of functional states of cancer-associated fibroblasts. Cancers 14, 3315 (2022).","journal-title":"Cancers"},{"key":"58893_CR31","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/cas.70026","volume":"116","author":"E Kimura","year":"2025","unstructured":"Kimura, E. et al. p53 deficiency in colon cancer cells promotes tumor progression through the modulation of meflin in fibroblasts. Cancer Sci. 116, 1871\u20131882 (2025).","journal-title":"Cancer Sci."},{"key":"58893_CR32","doi-asserted-by":"publisher","first-page":"749924","DOI":"10.3389\/fcell.2021.749924","volume":"9","author":"M Takahashi","year":"2021","unstructured":"Takahashi, M. et al. Roles of the mesenchymal stromal\/stem cell marker Meflin\/Islr in cancer fibrosis. Front. Cell. Dev. Biol. 9, 749924 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"58893_CR33","first-page":"484","volume":"84","author":"Y Shiraki","year":"2022","unstructured":"Shiraki, Y., Mii, S., Esaki, N. & Enomoto, A. Possible disease-protective roles of fibroblasts in cancer and fibrosis and their therapeutic application. Nagoya J. Med. Sci. 84, 484\u2013496 (2022).","journal-title":"Nagoya J. Med. Sci."},{"key":"58893_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI192804","author":"J Mu","year":"2026","unstructured":"Mu, J. et al. Meflin confers antifibrotic properties to intestinal fibroblasts in inflammatory bowel disease. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI192804 (2026).","journal-title":"J. Clin. Invest."},{"key":"58893_CR35","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/s41388-022-02288-9","volume":"41","author":"T Iida","year":"2022","unstructured":"Iida, T. et al. Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics. Oncogene 41, 2764\u20132777 (2022).","journal-title":"Oncogene"},{"key":"58893_CR36","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ajpath.2026.01.006","volume":"196","author":"A Sakai","year":"2026","unstructured":"Sakai, A. et al. Increased meflin expression in cancer-associated fibroblasts restrains tumor cell proliferation and shapes vessel-rich stroma in triple-negative breast cancer. Am. J. Pathol. 196, 1205\u20131219 (2026).","journal-title":"Am. J. Pathol."},{"key":"58893_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41416-024-02734-3","volume":"131","author":"T Owaki","year":"2024","unstructured":"Owaki, T. et al. Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade. Br. J. Cancer 131, 372\u2013386 (2024).","journal-title":"Br. J. Cancer"},{"key":"58893_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/geno.1997.4889","volume":"44","author":"A Nagasawa","year":"1997","unstructured":"Nagasawa, A. et al. Cloning of the cDNA for a new member of the immunoglobulin superfamily (ISLR) containing leucine-rich repeat (LRR). Genomics 44, 273\u2013279 (1997).","journal-title":"Genomics"},{"key":"58893_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","volume":"25","author":"A Bringmann","year":"2006","unstructured":"Bringmann, A. et al. M\u00fcller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 25, 397\u2013424 (2006).","journal-title":"Prog. Retin. Eye Res."},{"key":"58893_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70048","volume":"36","author":"Y Shiraki","year":"2026","unstructured":"Shiraki, Y. et al. Meflin\/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progression. Brain Pathol. 36, e70048 (2026).","journal-title":"Brain Pathol."},{"key":"58893_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128921","volume":"10","author":"M Nagaya","year":"2015","unstructured":"Nagaya, M. et al. Pikachurin protein required for increase of cone electroretinogram B-wave during light adaptation. PLoS One 10, e0128921 (2015).","journal-title":"PLoS One"},{"key":"58893_CR42","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 8, 2197\u20132211 (2013).","journal-title":"Nat. Protoc."},{"key":"58893_CR43","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.2.6","volume":"4","author":"R Ijima","year":"2015","unstructured":"Ijima, R. et al. Suppression of laser-induced choroidal neovascularization by the oral medicine targeting histamine receptor H4 in mice. Trans. Vis. Sci. Tech. 4, 6 (2015).","journal-title":"Trans. Vis. Sci. Tech."},{"key":"58893_CR44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41590-023-01437-w","volume":"24","author":"I Benhar","year":"2023","unstructured":"Benhar, I. et al. Temporal single-cell atlas of non-neuronal retinal cells reveals dynamic, coordinated multicellular responses to central nervous system injury. Nat. Immunol. 24, 700\u2013713 (2023).","journal-title":"Nat. Immunol."},{"key":"58893_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.898652","volume":"10","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Xia, Q., Zeng, Y., Zhang, Y. & Zhang, M. Regulations of retinal inflammation: Focusing on M\u00fcller glia. Front. Cell Dev. Biol. 10, 898652 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"58893_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.620459","volume":"8","author":"S Kang","year":"2021","unstructured":"Kang, S. et al. A comparative analysis of reactive M\u00fcller glia gene expression after light damage and microRNA-depleted M\u00fcller glia\u2014Focus on microRNAs. Front. Cell Dev. Biol. 8, 620459 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"58893_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32058-w","volume":"13","author":"K Eastlake","year":"2023","unstructured":"Eastlake, K. et al. Transcriptomics of CD29+\/CD44+ cells isolated from hPSC retinal organoids reveals a single cell population with retinal progenitor and M\u00fcller glia characteristics. Sci. Rep. 13, 5081 (2023).","journal-title":"Sci. Rep."},{"key":"58893_CR48","doi-asserted-by":"publisher","first-page":"11372","DOI":"10.1128\/JVI.01327-07","volume":"81","author":"M Allocca","year":"2007","unstructured":"Allocca, M. et al. Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J. Virol. 81, 11372\u201311380 (2007).","journal-title":"J. Virol."},{"key":"58893_CR49","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","volume":"22","author":"SJ Gray","year":"2011","unstructured":"Gray, S. J. et al. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum. Gene Ther. 22, 1143\u20131153 (2011).","journal-title":"Hum. Gene Ther."},{"key":"58893_CR50","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1167\/iovs.10-6266","volume":"52","author":"A Giani","year":"2011","unstructured":"Giani, A. et al. In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 52, 3880 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58893_CR51","doi-asserted-by":"publisher","first-page":"OCT331","DOI":"10.1167\/iovs.15-18946","volume":"57","author":"JR Park","year":"2016","unstructured":"Park, J. R. et al. Imaging laser-induced choroidal neovascularization in the rodent retina using optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 57, OCT331 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58893_CR52","doi-asserted-by":"publisher","first-page":"109428","DOI":"10.1016\/j.exer.2023.109428","volume":"229","author":"S Zandi","year":"2023","unstructured":"Zandi, S. et al. Animal model of subretinal fibrosis without active choroidal neovascularization. Exp. Eye Res. 229, 109428 (2023).","journal-title":"Exp. Eye Res."},{"key":"58893_CR53","doi-asserted-by":"crossref","unstructured":"Fuhrmann, S. Eye morphogenesis and patterning of the optic vesicle. Curr. Top. Dev. Biol. 93, 61\u201384 (2010).","DOI":"10.1016\/B978-0-12-385044-7.00003-5"},{"key":"58893_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.13-229740","volume":"28","author":"K Ishikawa","year":"2014","unstructured":"Ishikawa, K. et al. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J. 28, 131\u2013142 (2014).","journal-title":"FASEB J."},{"key":"58893_CR55","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1167\/iovs.05-1590","volume":"47","author":"S Aisenbrey","year":"2006","unstructured":"Aisenbrey, S. et al. Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through \u03b13- and \u03b16-containing integrins. Invest. Ophthalmol. Vis. Sci. 47, 5537 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58893_CR56","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev. 85, 845\u2013881 (2005).","journal-title":"Physiol. Rev."},{"key":"58893_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.exer.2015.02.004","volume":"142","author":"FJ Lovicu","year":"2016","unstructured":"Lovicu, F. J., Shin, E. H. & McAvoy, J. W. Fibrosis in the lens. Sprouty regulation of TGF\u03b2-signaling prevents lens EMT leading to cataract. Exp. Eye Res. 142, 92\u2013101 (2016).","journal-title":"Exp. Eye Res."},{"key":"58893_CR58","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0002-9440(10)63153-7","volume":"164","author":"S Saika","year":"2004","unstructured":"Saika, S. et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am. J. Pathol. 164, 651\u2013663 (2004).","journal-title":"Am. J. Pathol."},{"key":"58893_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0945-053X(01)00122-6","volume":"20","author":"E Hanssen","year":"2001","unstructured":"Hanssen, E. Synthesis and structural organization of zonular fibers during development and aging. Matrix Biol. 20, 77\u201385 (2001).","journal-title":"Matrix Biol."},{"key":"58893_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain, R. K. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307, 58\u201362 (2005).","journal-title":"Science"},{"key":"58893_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet, P. & Jain, R. K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417\u2013427 (2011).","journal-title":"Nat. Rev. Drug Discov"},{"key":"58893_CR62","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071\u20131121 (2011).","journal-title":"Physiol. Rev."},{"key":"58893_CR63","first-page":"305","volume":"87","author":"Y Morita","year":"2025","unstructured":"Morita, Y. et al. Meflin\/Islr is a marker of fibroblasts that arise in fibrotic regions after spinal cord injury. Nagoya J. Med. Sci. 87, 305\u2013319 (2025).","journal-title":"Nagoya J. Med. Sci."},{"key":"58893_CR64","doi-asserted-by":"publisher","first-page":"e0216304","DOI":"10.1371\/journal.pone.0216304","volume":"14","author":"Y Nakano","year":"2019","unstructured":"Nakano, Y. et al. Vascular maturity of type 1 and type 2 choroidal neovascularization evaluated by optical coherence tomography angiography. PLOS One\u00a014, e0216304 (2019).","journal-title":"PLOS One"},{"key":"58893_CR65","doi-asserted-by":"publisher","first-page":"e202001064","DOI":"10.1083\/jcb.202001064","volume":"219","author":"SJ Lord","year":"2020","unstructured":"Lord, S. J., Velle, K. B., Mullins, R. D. & Fritz-Laylin, L. K. SuperPlots: Communicating reproducibility and variability in cell biology. J. Cell Biol. 219, e202001064 (2020).","journal-title":"J. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58893-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58893-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58893-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:02:44Z","timestamp":1789689764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58893-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58893"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58893-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8930515\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29079"}}